simply_sim的个人主页 - 老虎社区

simply_sim

simply_sim

暂无个人介绍

IP属地：未知

5关注

16粉丝

0主题

0勋章

2021-09-14

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$did I miss something? Why keep going down?

2021-07-06

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$why drop when I went in?

2021-06-18

Pleasant surprise. Hopefully it will go up more.

抱歉，原内容已删除

2021-07-23

$KEPPEL DC REIT(AJBU.SI)$cd next week. Why still drop?

2021-12-27

Why?

Novavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote>

2021-08-23

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$why is it coming down?

2021-08-13

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$how does the bonus share work?

2021-07-27

$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$been in the range of 1.38 to 1.41. Need booster.

2021-12-18

Like

Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote>

2021-09-01

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?

2021-06-28

$THAI BEVERAGE PUBLIC CO LTD(Y92.SI)$good time to go in?

2021-06-26

Micron to the moon

Don't Miss What 3 Nasdaq Stocks Do Next Week<blockquote>不要错过下周3只纳斯达克股票的走势</blockquote>

2021-06-23

$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$low volume today

2021-06-19

Don't quite understand. Interest rates go up, won't rhe bank stocks benefit most?

Bank Stocks Were Fed Day Winners. Why They’re Getting Crushed.<blockquote>银行股是美联储日的赢家。为什么他们会被压垮。</blockquote>

2021-07-19

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$go go go. Go up.

2021-07-02

$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$too high to go in now?

2021-07-01

$KEPPEL DC REIT(AJBU.SI)$what happened?

2021-06-28

Woohoo

抱歉，原内容已删除

2021-06-21

Interesting.

Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme盘前交易涨超6%</blockquote>

2021-06-20

Article to instill fear?

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586573341987690","uuid":"3586573341987690","gmtCreate":1623479347958,"gmtModify":1626666866611,"name":"simply_sim","pinyin":"simplysimsimplysim","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":16,"headSize":5,"tweetSize":84,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":696831676,"gmtCreate":1640659361618,"gmtModify":1640659361842,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","listText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","text":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696831676","repostId":"1187889461","repostType":4,"repost":{"id":"1187889461","kind":"news","pubTimestamp":1640657510,"share":"https://www.laohu8.com/m/news/1187889461?lang=zh_CN&edition=full","pubTime":"2021-12-28 10:11","market":"us","language":"en","title":"Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187889461","media":"Motley Fool","summary":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The com","content":"<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>本公司之股份<b>Novavax</b>截至美国东部时间周一上午11:47，（纳斯达克：NVAX）股价下跌9.6%。该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的金融直播可能并没有让投资者放心。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-28 10:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>本公司之股份<b>Novavax</b>截至美国东部时间周一上午11:47，（纳斯达克：NVAX）股价下跌9.6%。该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的金融直播可能并没有让投资者放心。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187889461","content_text":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696310849,"gmtCreate":1640616693631,"gmtModify":1640616693922,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696310849","repostId":"1103486686","repostType":4,"repost":{"id":"1103486686","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640616531,"share":"https://www.laohu8.com/m/news/1103486686?lang=zh_CN&edition=full","pubTime":"2021-12-27 22:48","market":"us","language":"en","title":"Novavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1103486686","media":"Tiger Newspress","summary":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","content":"<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p><p><blockquote>Novavax股价早盘下跌8%。该股前一交易日下跌3.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-27 22:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p><p><blockquote>Novavax股价早盘下跌8%。该股前一交易日下跌3.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103486686","content_text":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069967,"gmtCreate":1640576213852,"gmtModify":1640576338966,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069967","repostId":"1134678244","repostType":4,"isVote":1,"tweetType":1,"viewCount":3437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069020,"gmtCreate":1640576187400,"gmtModify":1640576338772,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Novavac go!","listText":"Novavac go!","text":"Novavac go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069020","repostId":"2194177711","repostType":4,"isVote":1,"tweetType":1,"viewCount":2474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691745922,"gmtCreate":1640251620512,"gmtModify":1640251620735,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Woohoo&nbsp;","listText":"Woohoo&nbsp;","text":"Woohoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691745922","repostId":"1136917991","repostType":4,"repost":{"id":"1136917991","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640250865,"share":"https://www.laohu8.com/m/news/1136917991?lang=zh_CN&edition=full","pubTime":"2021-12-23 17:14","market":"us","language":"en","title":"Novavax shares rose 5.56% in premarket trading.<blockquote>Novavax股价在盘前交易中上涨5.56%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1136917991","media":"Tiger Newspress","summary":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in genera","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p><p><blockquote>Novavax股价在盘前交易中上涨5.根据周三公布的早期数据，Novavax Inc.的COVID-19疫苗可以有效地产生针对奥密克戎变种的免疫反应，这表明这家美国制药商现有的COVID-19疫苗可以帮助对抗新的奥密克戎变种。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares rose 5.56% in premarket trading.<blockquote>Novavax股价在盘前交易中上涨5.56%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares rose 5.56% in premarket trading.<blockquote>Novavax股价在盘前交易中上涨5.56%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-23 17:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p><p><blockquote>Novavax股价在盘前交易中上涨5.根据周三公布的早期数据，Novavax Inc.的COVID-19疫苗可以有效地产生针对奥密克戎变种的免疫反应，这表明这家美国制药商现有的COVID-19疫苗可以帮助对抗新的奥密克戎变种。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136917991","content_text":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699208690,"gmtCreate":1639800700087,"gmtModify":1639800700312,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699208690","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=zh_CN&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p><p><blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单。世界卫生组织已将其疫苗NVX-CoV2373列入紧急使用清单，其名为nuvaxovidtm的原研药物目前正在接受欧洲药品管理局的评估。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-17 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p><p><blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单。世界卫生组织已将其疫苗NVX-CoV2373列入紧急使用清单，其名为nuvaxovidtm的原研药物目前正在接受欧洲药品管理局的评估。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844582229,"gmtCreate":1636441127037,"gmtModify":1636441127391,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"What happened?","listText":"What happened?","text":"What happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844582229","repostId":"844277031","repostType":1,"repost":{"id":844277031,"gmtCreate":1636435957907,"gmtModify":1636435958916,"author":{"id":"4090651426001740","authorId":"4090651426001740","name":"HKpoh","avatar":"https://static.tigerbbs.com/c7e76b0a89262ef58fedef12ced230ca","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090651426001740","authorIdStr":"4090651426001740"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","text":"$扬子江船业(BS6.SI)$发生什么事🤔？？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844277031","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842664683,"gmtCreate":1636171472420,"gmtModify":1636171472748,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","text":"$Novavax(NVAX)$doesn't look good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842664683","isVote":1,"tweetType":1,"viewCount":2547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855803222,"gmtCreate":1635346455848,"gmtModify":1635346456553,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","listText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","text":"$MasterCard(MA)$dragged down by visa?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855803222","isVote":1,"tweetType":1,"viewCount":2036,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826448644,"gmtCreate":1634049347431,"gmtModify":1634049347792,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","text":"$Micron Technology(MU)$sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826448644","isVote":1,"tweetType":1,"viewCount":2561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829203450,"gmtCreate":1633508099969,"gmtModify":1633508100314,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","text":"$KEPPEL DC REIT(AJBU.SI)$what happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829203450","isVote":1,"tweetType":1,"viewCount":543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862915798,"gmtCreate":1632828667637,"gmtModify":1632828667733,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","text":"$Micron Technology(MU)$premarket an indication of not so good results?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862915798","isVote":1,"tweetType":1,"viewCount":1078,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":886264644,"gmtCreate":1631596513188,"gmtModify":1631884136589,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>did I miss something? Why keep going down?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>did I miss something? Why keep going down?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$did I miss something? Why keep going down?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/886264644","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883708414,"gmtCreate":1631269700538,"gmtModify":1631884136600,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ME8U.SI\">$MAPLETREE INDUSTRIAL TRUST(ME8U.SI)$</a>more of today's movement please","listText":"<a href=\"https://laohu8.com/S/ME8U.SI\">$MAPLETREE INDUSTRIAL TRUST(ME8U.SI)$</a>more of today's movement please","text":"$MAPLETREE INDUSTRIAL TRUST(ME8U.SI)$more of today's movement please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883708414","isVote":1,"tweetType":1,"viewCount":630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889945338,"gmtCreate":1631107036424,"gmtModify":1631884136613,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"Master, master, master,","listText":"Master, master, master,","text":"Master, master, master,","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/889945338","repostId":"2165351919","repostType":2,"repost":{"id":"2165351919","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1631022394,"share":"https://www.laohu8.com/m/news/2165351919?lang=zh_CN&edition=full","pubTime":"2021-09-07 21:46","market":"hk","language":"en","title":"Danske Bank Sells Its Shares In Aiia To Mastercard<blockquote>丹麦银行将其在Aiia的股份出售给万事达卡</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2165351919","media":"T-Reuters","summary":"Danske Bank A/S :Sells Its Shares In Aiia To Mastercard.Transaction Does Not Entail Any Revision Of ","content":"<p><html><body><a href=\"https://laohu8.com/S/DNKEY\">Danske Bank A/S</a> <danske.co>:Sells Its Shares In Aiia To Mastercard.Transaction Does Not Entail Any Revision Of Co'S Current Outlook For Full-Year Result.Further Company Coverage: Danske.Co. (Gdansk Newsroom). ((Gdansk.Newsroom@Thomsonreuters.Com; +48 58 769 66 00;)).</danske.co></p><p><blockquote><html><body><a href=\"https://laohu8.com/S/DNKEY\">丹麦银行A/S</a><danske.co>：将其在Aiia的股份出售给万事达卡。交易并不需要对Co当前的全年业绩前景进行任何修正。进一步的公司报道：Danske.Co。（格但斯克新闻编辑室）。（（Gdansk.Newsroom@Thomsonreuters.Com；+48 58 769 66 00；））。</danske.co></body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Danske Bank Sells Its Shares In Aiia To Mastercard<blockquote>丹麦银行将其在Aiia的股份出售给万事达卡</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDanske Bank Sells Its Shares In Aiia To Mastercard<blockquote>丹麦银行将其在Aiia的股份出售给万事达卡</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time smaller\">2021-09-07 21:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body><a href=\"https://laohu8.com/S/DNKEY\">Danske Bank A/S</a> <danske.co>:Sells Its Shares In Aiia To Mastercard.Transaction Does Not Entail Any Revision Of Co'S Current Outlook For Full-Year Result.Further Company Coverage: Danske.Co. (Gdansk Newsroom). ((Gdansk.Newsroom@Thomsonreuters.Com; +48 58 769 66 00;)).</danske.co></p><p><blockquote><html><body><a href=\"https://laohu8.com/S/DNKEY\">丹麦银行A/S</a><danske.co>：将其在Aiia的股份出售给万事达卡。交易并不需要对Co当前的全年业绩前景进行任何修正。进一步的公司报道：Danske.Co。（格但斯克新闻编辑室）。（（Gdansk.Newsroom@Thomsonreuters.Com；+48 58 769 66 00；））。</danske.co></body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MA":"万事达"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165351919","content_text":"Danske Bank A/S :Sells Its Shares In Aiia To Mastercard.Transaction Does Not Entail Any Revision Of Co'S Current Outlook For Full-Year Result.Further Company Coverage: Danske.Co. (Gdansk Newsroom). ((Gdansk.Newsroom@Thomsonreuters.Com; +48 58 769 66 00;)).","news_type":1,"symbols_score_info":{"MA":1}},"isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816327734,"gmtCreate":1630469806528,"gmtModify":1631884136623,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?&nbsp;","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?&nbsp;","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/816327734","isVote":1,"tweetType":1,"viewCount":1214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819673211,"gmtCreate":1630069759233,"gmtModify":1704955467351,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>time to go up","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>time to go up","text":"$Micron Technology(MU)$time to go up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819673211","isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837261197,"gmtCreate":1629894344619,"gmtModify":1631884136639,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>up up up","listText":"<a href=\"https://laohu8.com/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>up up up","text":"$FRENCKEN GROUP LIMITED(E28.SI)$up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837261197","isVote":1,"tweetType":1,"viewCount":463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834658539,"gmtCreate":1629800394721,"gmtModify":1631884103148,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MZH.SI\">$Nanofilm(MZH.SI)$</a>still a long way to 6","listText":"<a href=\"https://laohu8.com/S/MZH.SI\">$Nanofilm(MZH.SI)$</a>still a long way to 6","text":"$Nanofilm(MZH.SI)$still a long way to 6","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834658539","isVote":1,"tweetType":1,"viewCount":673,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835639329,"gmtCreate":1629709267361,"gmtModify":1631884136647,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586573341987690","authorIdStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why is it coming down?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why is it coming down?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$why is it coming down?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/835639329","isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":886264644,"gmtCreate":1631596513188,"gmtModify":1631884136589,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>did I miss something? Why keep going down?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>did I miss something? Why keep going down?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$did I miss something? Why keep going down?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/886264644","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157006599,"gmtCreate":1625550460611,"gmtModify":1631884682406,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why drop when I went in?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why drop when I went in?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$why drop when I went in?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/157006599","isVote":1,"tweetType":1,"viewCount":1261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168487809,"gmtCreate":1623981037601,"gmtModify":1634024795283,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Pleasant surprise. Hopefully it will go up more.","listText":"Pleasant surprise. Hopefully it will go up more.","text":"Pleasant surprise. Hopefully it will go up more.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/168487809","repostId":"2144286417","repostType":4,"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175855673,"gmtCreate":1627025320092,"gmtModify":1631888415030,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>cd next week. Why still drop?","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>cd next week. Why still drop?","text":"$KEPPEL DC REIT(AJBU.SI)$cd next week. Why still drop?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/175855673","isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696310849,"gmtCreate":1640616693631,"gmtModify":1640616693922,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696310849","repostId":"1103486686","repostType":4,"repost":{"id":"1103486686","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640616531,"share":"https://www.laohu8.com/m/news/1103486686?lang=zh_CN&edition=full","pubTime":"2021-12-27 22:48","market":"us","language":"en","title":"Novavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1103486686","media":"Tiger Newspress","summary":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","content":"<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p><p><blockquote>Novavax股价早盘下跌8%。该股前一交易日下跌3.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped 8% in morning trading<blockquote>Novavax股价早盘下跌8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-27 22:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p><p><blockquote>Novavax股价早盘下跌8%。该股前一交易日下跌3.3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103486686","content_text":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":835639329,"gmtCreate":1629709267361,"gmtModify":1631884136647,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why is it coming down?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>why is it coming down?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$why is it coming down?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/835639329","isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894408896,"gmtCreate":1628844227615,"gmtModify":1631884136657,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>how does the bonus share work?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>how does the bonus share work?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$how does the bonus share work?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/894408896","isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":809623557,"gmtCreate":1627367146279,"gmtModify":1631884136714,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>been in the range of 1.38 to 1.41. Need booster.","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>been in the range of 1.38 to 1.41. Need booster.","text":"$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$been in the range of 1.38 to 1.41. Need booster.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/809623557","isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699208690,"gmtCreate":1639800700087,"gmtModify":1639800700312,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699208690","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=zh_CN&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p><p><blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单。世界卫生组织已将其疫苗NVX-CoV2373列入紧急使用清单，其名为nuvaxovidtm的原研药物目前正在接受欧洲药品管理局的评估。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list<blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-17 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p><p><blockquote>Novavax早盘继续上涨近5%，因其疫苗已被列入紧急使用清单。世界卫生组织已将其疫苗NVX-CoV2373列入紧急使用清单，其名为nuvaxovidtm的原研药物目前正在接受欧洲药品管理局的评估。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":816327734,"gmtCreate":1630469806528,"gmtModify":1631884136623,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?&nbsp;","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?&nbsp;","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$anybody can advise whether one would be entitled the bonus shares if the shares are bought over tiger platform?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/816327734","isVote":1,"tweetType":1,"viewCount":1214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127544970,"gmtCreate":1624859115890,"gmtModify":1631887034133,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/Y92.SI\">$THAI BEVERAGE PUBLIC CO LTD(Y92.SI)$</a>good time to go in?","listText":"<a href=\"https://laohu8.com/S/Y92.SI\">$THAI BEVERAGE PUBLIC CO LTD(Y92.SI)$</a>good time to go in?","text":"$THAI BEVERAGE PUBLIC CO LTD(Y92.SI)$good time to go in?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/127544970","isVote":1,"tweetType":1,"viewCount":915,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125568179,"gmtCreate":1624680768191,"gmtModify":1631890772598,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Micron to the moon","listText":"Micron to the moon","text":"Micron to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/125568179","repostId":"1152075524","repostType":2,"repost":{"id":"1152075524","kind":"news","pubTimestamp":1624666599,"share":"https://www.laohu8.com/m/news/1152075524?lang=zh_CN&edition=full","pubTime":"2021-06-26 08:16","market":"us","language":"en","title":"Don't Miss What 3 Nasdaq Stocks Do Next Week<blockquote>不要错过下周3只纳斯达克股票的走势</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152075524","media":"Motley Fool","summary":"The stock market has done well recently, and the favorable sentiment has sent the Nasdaq Composite(N","content":"<p>The stock market has done well recently, and the favorable sentiment has sent the&nbsp;<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)&nbsp;to record levels. On Friday, the Nasdaq closed a strong week on a quiet note.</p><p><blockquote>近期股市表现不错，利好情绪送<b>纳斯达克复合材料</b>（纳斯达克指数：^IXIC）创历史新高。周五，纳斯达克以平静的基调结束了强劲的一周。</blockquote></p><p> We're almost halfway through 2021, and investors are trying to get a read on how the second half of the year will go. Despite the current lull in corporate earnings releases, market participants will get three key readings from major companies next week.Nasdaqinvestors should treat these reports as must-read news that could move markets as we pass the six-month mark in the current year.</p><p><blockquote>2021年已过半，投资者正试图了解下半年的情况。尽管目前企业财报发布平静，但市场参与者下周将获得大公司的三份关键数据。纳斯达克投资者应将这些报告视为必读新闻，这些新闻可能会在我们今年突破六个月大关时推动市场。</blockquote></p><p> <b>Bed Bath &amp; Beyond</b></p><p><blockquote><b>贝德柏士比昂公司</b></blockquote></p><p> <b>Bed Bath &amp; Beyond</b>&nbsp;(NASDAQ:BBBY)&nbsp;will report its fiscal first-quarter results on Wednesday morning, June 30. Thehome furnishings stock&nbsp;has gotten a lot of attention both because of its turnaround efforts and because of its relatively new status as a meme stock followed by individual investors.</p><p><blockquote><b>贝德柏士比昂公司</b>（纳斯达克：BBBY）将于6月30日星期三上午公布第一财季业绩。家居用品股票受到了很多关注，既是因为它的扭亏为盈努力，也是因为它作为个人投资者关注的模因股票的相对较新的地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/417e33a9c1d841f220a2b37d2e368a64\" tg-width=\"2000\" tg-height=\"1333\" referrerpolicy=\"no-referrer\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> Bed Bath &amp; Beyond has struggled over the past several years as it fought to come up with a digital strategy to fend off competition from e-commerce giants. Many saw the business as ultimately doomed, and the stock got substantial short interest among investors as a result. Yet activist investors stepped in and aimed to concentrate on the company's most lucrative business opportunities, and now, some shareholders are optimistic about Bed Bath &amp; Beyond's ability to cash in on the reopening economy.</p><p><blockquote>过去几年，Bed Bath&amp;Beyond一直在努力制定数字战略来抵御电子商务巨头的竞争。许多人认为该业务最终注定要失败，因此该股获得了投资者的大量空头兴趣。然而，激进投资者介入并旨在专注于该公司最有利可图的商业机会，现在，一些股东对贝德柏士比昂公司从重新开放的经济中获利的能力持乐观态度。</blockquote></p><p> Investors have high hopes for the coming report, expecting Bed Bath &amp; Beyond to return to profitability and produce impressive revenue growth of around 35%. After the gains the share price has seen in the past week, anything short of those lofty aspirations could cause an abrupt reversal for the meme stock's prospects.</p><p><blockquote>投资者对即将发布的报告寄予厚望，预计Bed Bath&amp;Beyond将恢复盈利，并实现35%左右的令人印象深刻的收入增长。在过去一周股价上涨之后，任何达不到这些崇高愿望的事情都可能导致模因股票的前景突然逆转。</blockquote></p><p> <b>Micron Technology</b></p><p><blockquote><b>美光科技</b></blockquote></p><p> Chipmaker&nbsp;<b>Micron Technology</b>(NASDAQ:MU)&nbsp;weighs in with its fiscal third-quarter report on Wednesday afternoon. The company has taken full advantage of huge rises in demand for memory chips and other products, but investors have seemed increasingly nervous abouthow long Micron's demand will lastgiven the notoriously cyclical nature of the semiconductor chip industry.</p><p><blockquote>芯片制造商<b>美光科技</b>（纳斯达克：MU）周三下午发布了第三财季报告。该公司充分利用了存储芯片和其他产品需求的大幅增长，但鉴于半导体芯片行业众所周知的周期性，投资者似乎越来越担心美光的需求能持续多久。</blockquote></p><p> To be clear, few investors have any doubts about the strength of the just-ended quarter. Most of those following the stock expect earnings to double year over year, with revenue climbing at a faster than 35% pace. Many see that growth continuing well into next year. The consensus forecast for fiscal 2022 earnings puts a forward multiple of just 8 on Micron's share price.</p><p><blockquote>需要明确的是，很少有投资者对刚刚结束的季度的实力有任何怀疑。大多数关注该股的人预计盈利将同比翻一番，收入增长速度将超过35%。许多人认为这种增长将持续到明年。对2022财年盈利的普遍预测显示，美光科技股价的预期倍数仅为8倍。</blockquote></p><p> The key question is how quickly Micron and its competitors will ramp up production capacity in order to meet higher demand. In the past, upward cycles in the chip market ended because companies like Micron boost production too far, creating gluts of chips and sending prices plunging. That in turn crushes profits, making low price-to-earnings ratios into value traps for the unwary. All eyes will be on Micron's report to see not only how things have gone, but also what the future holds for it and its rivals.</p><p><blockquote>关键问题是美光及其竞争对手将以多快的速度提高产能以满足更高的需求。过去，芯片市场的上行周期结束是因为美光等公司过度提高产量，造成芯片过剩并导致价格暴跌。这反过来又会挤压利润，使低市盈率成为粗心者的价值陷阱。所有人的目光都将关注美光科技的报告，不仅要了解事情的进展情况，还要了解其及其竞争对手的未来。</blockquote></p><p> <b>Walgreens Boots Alliance</b></p><p><blockquote><b>沃尔格林靴子联盟</b></blockquote></p><p> Lastly,<b>Walgreen Boots Alliance</b>(NASDAQ:WBA)&nbsp;will offer its latest look at earnings on Thursday, July 1. Investors are expecting a mixed picture from the giant drugstore chain, with revenue likely slipping a bit from year-ago levels but profits jumping by nearly 65%.</p><p><blockquote>最后，<b>沃尔格林靴子联盟</b>（纳斯达克：WBA）将于7月1日星期四公布最新财报。投资者预计这家大型连锁药店的前景好坏参半，收入可能较去年同期略有下滑，但利润将增长近65%。</blockquote></p><p> Investors will watch&nbsp;how Walgreens has done&nbsp;in administering COVID-19 vaccines, which has been a one-time boon for the industry generally. However, of greater long-term concern will be any comments on whether the possibility of e-commerce giant&nbsp;<b>Amazon</b>(NASDAQ:AMZN)&nbsp;challenging Walgreens' business more directly could cause problems.</p><p><blockquote>投资者将关注沃尔格林在接种COVID-19疫苗方面的表现，这对整个行业来说是一次性的福音。不过，更值得长期关注的将是任何评论是否有可能成为电商巨头<b>亚马逊</b>（纳斯达克：AMZN）更直接地挑战沃尔格林的业务可能会引发问题。</blockquote></p><p> Walgreens will have to have a strategy for how to build on momentum from COVID-related impacts. If the drugstore chain can't deliver, then the relatively stagnant performance of its stock could continue further into 2021 and potentially beyond.</p><p><blockquote>沃尔格林必须制定一项战略，说明如何利用新冠疫情相关影响的势头。如果这家连锁药店无法交付，那么其股票相对停滞的表现可能会持续到2021年甚至更久。</blockquote></p><p> <b>Watch out for surprises</b></p><p><blockquote><b>小心惊喜</b></blockquote></p><p> News that's close to what investors expect likely won't make a big difference for any of these three stocks or the stock market more broadly. But if any of these companies has a big surprise, it could turn out to be what moves the Nasdaq heading into the July 4 holiday weekend.</p><p><blockquote>接近投资者预期的消息可能不会对这三只股票或更广泛的股市产生太大影响。但如果这些公司中的任何一家有一个大惊喜，这可能会导致纳斯达克进入7月4日假期周末。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Miss What 3 Nasdaq Stocks Do Next Week<blockquote>不要错过下周3只纳斯达克股票的走势</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Miss What 3 Nasdaq Stocks Do Next Week<blockquote>不要错过下周3只纳斯达克股票的走势</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-06-26 08:16</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The stock market has done well recently, and the favorable sentiment has sent the&nbsp;<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)&nbsp;to record levels. On Friday, the Nasdaq closed a strong week on a quiet note.</p><p><blockquote>近期股市表现不错，利好情绪送<b>纳斯达克复合材料</b>（纳斯达克指数：^IXIC）创历史新高。周五，纳斯达克以平静的基调结束了强劲的一周。</blockquote></p><p> We're almost halfway through 2021, and investors are trying to get a read on how the second half of the year will go. Despite the current lull in corporate earnings releases, market participants will get three key readings from major companies next week.Nasdaqinvestors should treat these reports as must-read news that could move markets as we pass the six-month mark in the current year.</p><p><blockquote>2021年已过半，投资者正试图了解下半年的情况。尽管目前企业财报发布平静，但市场参与者下周将获得大公司的三份关键数据。纳斯达克投资者应将这些报告视为必读新闻，这些新闻可能会在我们今年突破六个月大关时推动市场。</blockquote></p><p> <b>Bed Bath &amp; Beyond</b></p><p><blockquote><b>贝德柏士比昂公司</b></blockquote></p><p> <b>Bed Bath &amp; Beyond</b>&nbsp;(NASDAQ:BBBY)&nbsp;will report its fiscal first-quarter results on Wednesday morning, June 30. Thehome furnishings stock&nbsp;has gotten a lot of attention both because of its turnaround efforts and because of its relatively new status as a meme stock followed by individual investors.</p><p><blockquote><b>贝德柏士比昂公司</b>（纳斯达克：BBBY）将于6月30日星期三上午公布第一财季业绩。家居用品股票受到了很多关注，既是因为它的扭亏为盈努力，也是因为它作为个人投资者关注的模因股票的相对较新的地位。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/417e33a9c1d841f220a2b37d2e368a64\" tg-width=\"2000\" tg-height=\"1333\" referrerpolicy=\"no-referrer\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> Bed Bath &amp; Beyond has struggled over the past several years as it fought to come up with a digital strategy to fend off competition from e-commerce giants. Many saw the business as ultimately doomed, and the stock got substantial short interest among investors as a result. Yet activist investors stepped in and aimed to concentrate on the company's most lucrative business opportunities, and now, some shareholders are optimistic about Bed Bath &amp; Beyond's ability to cash in on the reopening economy.</p><p><blockquote>过去几年，Bed Bath&amp;Beyond一直在努力制定数字战略来抵御电子商务巨头的竞争。许多人认为该业务最终注定要失败，因此该股获得了投资者的大量空头兴趣。然而，激进投资者介入并旨在专注于该公司最有利可图的商业机会，现在，一些股东对贝德柏士比昂公司从重新开放的经济中获利的能力持乐观态度。</blockquote></p><p> Investors have high hopes for the coming report, expecting Bed Bath &amp; Beyond to return to profitability and produce impressive revenue growth of around 35%. After the gains the share price has seen in the past week, anything short of those lofty aspirations could cause an abrupt reversal for the meme stock's prospects.</p><p><blockquote>投资者对即将发布的报告寄予厚望，预计Bed Bath&amp;Beyond将恢复盈利，并实现35%左右的令人印象深刻的收入增长。在过去一周股价上涨之后，任何达不到这些崇高愿望的事情都可能导致模因股票的前景突然逆转。</blockquote></p><p> <b>Micron Technology</b></p><p><blockquote><b>美光科技</b></blockquote></p><p> Chipmaker&nbsp;<b>Micron Technology</b>(NASDAQ:MU)&nbsp;weighs in with its fiscal third-quarter report on Wednesday afternoon. The company has taken full advantage of huge rises in demand for memory chips and other products, but investors have seemed increasingly nervous abouthow long Micron's demand will lastgiven the notoriously cyclical nature of the semiconductor chip industry.</p><p><blockquote>芯片制造商<b>美光科技</b>（纳斯达克：MU）周三下午发布了第三财季报告。该公司充分利用了存储芯片和其他产品需求的大幅增长，但鉴于半导体芯片行业众所周知的周期性，投资者似乎越来越担心美光的需求能持续多久。</blockquote></p><p> To be clear, few investors have any doubts about the strength of the just-ended quarter. Most of those following the stock expect earnings to double year over year, with revenue climbing at a faster than 35% pace. Many see that growth continuing well into next year. The consensus forecast for fiscal 2022 earnings puts a forward multiple of just 8 on Micron's share price.</p><p><blockquote>需要明确的是，很少有投资者对刚刚结束的季度的实力有任何怀疑。大多数关注该股的人预计盈利将同比翻一番，收入增长速度将超过35%。许多人认为这种增长将持续到明年。对2022财年盈利的普遍预测显示，美光科技股价的预期倍数仅为8倍。</blockquote></p><p> The key question is how quickly Micron and its competitors will ramp up production capacity in order to meet higher demand. In the past, upward cycles in the chip market ended because companies like Micron boost production too far, creating gluts of chips and sending prices plunging. That in turn crushes profits, making low price-to-earnings ratios into value traps for the unwary. All eyes will be on Micron's report to see not only how things have gone, but also what the future holds for it and its rivals.</p><p><blockquote>关键问题是美光及其竞争对手将以多快的速度提高产能以满足更高的需求。过去，芯片市场的上行周期结束是因为美光等公司过度提高产量，造成芯片过剩并导致价格暴跌。这反过来又会挤压利润，使低市盈率成为粗心者的价值陷阱。所有人的目光都将关注美光科技的报告，不仅要了解事情的进展情况，还要了解其及其竞争对手的未来。</blockquote></p><p> <b>Walgreens Boots Alliance</b></p><p><blockquote><b>沃尔格林靴子联盟</b></blockquote></p><p> Lastly,<b>Walgreen Boots Alliance</b>(NASDAQ:WBA)&nbsp;will offer its latest look at earnings on Thursday, July 1. Investors are expecting a mixed picture from the giant drugstore chain, with revenue likely slipping a bit from year-ago levels but profits jumping by nearly 65%.</p><p><blockquote>最后，<b>沃尔格林靴子联盟</b>（纳斯达克：WBA）将于7月1日星期四公布最新财报。投资者预计这家大型连锁药店的前景好坏参半，收入可能较去年同期略有下滑，但利润将增长近65%。</blockquote></p><p> Investors will watch&nbsp;how Walgreens has done&nbsp;in administering COVID-19 vaccines, which has been a one-time boon for the industry generally. However, of greater long-term concern will be any comments on whether the possibility of e-commerce giant&nbsp;<b>Amazon</b>(NASDAQ:AMZN)&nbsp;challenging Walgreens' business more directly could cause problems.</p><p><blockquote>投资者将关注沃尔格林在接种COVID-19疫苗方面的表现，这对整个行业来说是一次性的福音。不过，更值得长期关注的将是任何评论是否有可能成为电商巨头<b>亚马逊</b>（纳斯达克：AMZN）更直接地挑战沃尔格林的业务可能会引发问题。</blockquote></p><p> Walgreens will have to have a strategy for how to build on momentum from COVID-related impacts. If the drugstore chain can't deliver, then the relatively stagnant performance of its stock could continue further into 2021 and potentially beyond.</p><p><blockquote>沃尔格林必须制定一项战略，说明如何利用新冠疫情相关影响的势头。如果这家连锁药店无法交付，那么其股票相对停滞的表现可能会持续到2021年甚至更久。</blockquote></p><p> <b>Watch out for surprises</b></p><p><blockquote><b>小心惊喜</b></blockquote></p><p> News that's close to what investors expect likely won't make a big difference for any of these three stocks or the stock market more broadly. But if any of these companies has a big surprise, it could turn out to be what moves the Nasdaq heading into the July 4 holiday weekend.</p><p><blockquote>接近投资者预期的消息可能不会对这三只股票或更广泛的股市产生太大影响。但如果这些公司中的任何一家有一个大惊喜，这可能会导致纳斯达克进入7月4日假期周末。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/06/25/dont-miss-what-3-nasdaq-stocks-do-next-week/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WBA":"沃尔格林联合博姿","BBBY":"Bed Bath & Beyond, Inc.","MU":"美光科技"},"source_url":"https://www.fool.com/investing/2021/06/25/dont-miss-what-3-nasdaq-stocks-do-next-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152075524","content_text":"The stock market has done well recently, and the favorable sentiment has sent the Nasdaq Composite(NASDAQINDEX:^IXIC) to record levels. On Friday, the Nasdaq closed a strong week on a quiet note.\nWe're almost halfway through 2021, and investors are trying to get a read on how the second half of the year will go. Despite the current lull in corporate earnings releases, market participants will get three key readings from major companies next week.Nasdaqinvestors should treat these reports as must-read news that could move markets as we pass the six-month mark in the current year.\nBed Bath & Beyond\nBed Bath & Beyond (NASDAQ:BBBY) will report its fiscal first-quarter results on Wednesday morning, June 30. Thehome furnishings stock has gotten a lot of attention both because of its turnaround efforts and because of its relatively new status as a meme stock followed by individual investors.\nIMAGE SOURCE: GETTY IMAGES.\nBed Bath & Beyond has struggled over the past several years as it fought to come up with a digital strategy to fend off competition from e-commerce giants. Many saw the business as ultimately doomed, and the stock got substantial short interest among investors as a result. Yet activist investors stepped in and aimed to concentrate on the company's most lucrative business opportunities, and now, some shareholders are optimistic about Bed Bath & Beyond's ability to cash in on the reopening economy.\nInvestors have high hopes for the coming report, expecting Bed Bath & Beyond to return to profitability and produce impressive revenue growth of around 35%. After the gains the share price has seen in the past week, anything short of those lofty aspirations could cause an abrupt reversal for the meme stock's prospects.\nMicron Technology\nChipmaker Micron Technology(NASDAQ:MU) weighs in with its fiscal third-quarter report on Wednesday afternoon. The company has taken full advantage of huge rises in demand for memory chips and other products, but investors have seemed increasingly nervous abouthow long Micron's demand will lastgiven the notoriously cyclical nature of the semiconductor chip industry.\nTo be clear, few investors have any doubts about the strength of the just-ended quarter. Most of those following the stock expect earnings to double year over year, with revenue climbing at a faster than 35% pace. Many see that growth continuing well into next year. The consensus forecast for fiscal 2022 earnings puts a forward multiple of just 8 on Micron's share price.\nThe key question is how quickly Micron and its competitors will ramp up production capacity in order to meet higher demand. In the past, upward cycles in the chip market ended because companies like Micron boost production too far, creating gluts of chips and sending prices plunging. That in turn crushes profits, making low price-to-earnings ratios into value traps for the unwary. All eyes will be on Micron's report to see not only how things have gone, but also what the future holds for it and its rivals.\nWalgreens Boots Alliance\nLastly,Walgreen Boots Alliance(NASDAQ:WBA) will offer its latest look at earnings on Thursday, July 1. Investors are expecting a mixed picture from the giant drugstore chain, with revenue likely slipping a bit from year-ago levels but profits jumping by nearly 65%.\nInvestors will watch how Walgreens has done in administering COVID-19 vaccines, which has been a one-time boon for the industry generally. However, of greater long-term concern will be any comments on whether the possibility of e-commerce giant Amazon(NASDAQ:AMZN) challenging Walgreens' business more directly could cause problems.\nWalgreens will have to have a strategy for how to build on momentum from COVID-related impacts. If the drugstore chain can't deliver, then the relatively stagnant performance of its stock could continue further into 2021 and potentially beyond.\nWatch out for surprises\nNews that's close to what investors expect likely won't make a big difference for any of these three stocks or the stock market more broadly. But if any of these companies has a big surprise, it could turn out to be what moves the Nasdaq heading into the July 4 holiday weekend.","news_type":1,"symbols_score_info":{"WBA":0.9,"BBBY":0.9,"MU":0.9}},"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123175659,"gmtCreate":1624413939371,"gmtModify":1631887059822,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>low volume today","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>low volume today","text":"$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$low volume today","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/123175659","isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165880938,"gmtCreate":1624115682424,"gmtModify":1634010570005,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Don't quite understand. Interest rates go up, won't rhe bank stocks benefit most?","listText":"Don't quite understand. Interest rates go up, won't rhe bank stocks benefit most?","text":"Don't quite understand. Interest rates go up, won't rhe bank stocks benefit most?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/165880938","repostId":"1119296361","repostType":4,"repost":{"id":"1119296361","kind":"news","pubTimestamp":1624028454,"share":"https://www.laohu8.com/m/news/1119296361?lang=zh_CN&edition=full","pubTime":"2021-06-18 23:00","market":"us","language":"en","title":"Bank Stocks Were Fed Day Winners. Why They’re Getting Crushed.<blockquote>银行股是美联储日的赢家。为什么他们会被压垮。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119296361","media":"Barrons","summary":"Bank stocks rosewhen the Fed released its June monetary policy statement, one thatpointed to earlier","content":"<p>Bank stocks rosewhen the Fed released its June monetary policy statement, one thatpointed to earlier than expected rate hikes. On Thursday, they were among the market’s biggest losers.</p><p><blockquote>当美联储发布6月份货币政策声明时，银行股上涨，该声明指出加息时间早于预期。周四，他们是市场最大的输家之一。</blockquote></p><p> There’s a good reason for that. Banks generally make money by borrowing money short and lending it out long—andmaking a profit off the spread. When longer-term rates rise faster than shorter-term ones, bank margins generally get better, while the profits deteriorate when the opposite happens.</p><p><blockquote>这是有充分理由的。银行通常通过短期借钱和长期借钱来赚钱，并从利差中获利。当长期利率上升速度快于短期利率时，银行利润率通常会提高，而当情况相反时，利润会恶化。</blockquote></p><p> After Wednesday’s meeting, the 10-year yield got a big bounce—it rose 0.071% to 1.569%—while thetwo-year yield rose0.038 percentage point to 0.203%, putting the spread between the two at 1.366 percentage points. That widening made the financial sector generally, and bank stocks specifically, one of the few sectors to react positively to the Fed’s announcement on Wednesday. TheSPDR S&amp;P Bank ETF(KBE) rose 0.9%, whileJPMorgan Chase(JPM) rose 0.7%, even as theS&amp;P 500fell 0.5%, theDow Jones Industrial Averagedropped 0.8%, and theNasdaq Compositedeclined 0.2%</p><p><blockquote>周三会议结束后，10年期国债收益率大幅反弹，上涨0.071%至1.569%，而两年期国债收益率上涨0.038个百分点至0.203%，两者利差达到1.366个百分点。这种扩大使得金融业，尤其是银行股成为少数几个对美联储周三的声明做出积极反应的行业之一。SPDR S&amp;P Bank ETF(KBE)上涨0.9%，摩根大通(JPM)上涨0.7%，尽管标准普尔500指数下跌0.5%，道琼斯工业平均指数下跌0.8%，纳斯达克综合指数下跌0.2%</blockquote></p><p> The market, however, has had a change of heart. The 10-year yield has fallen to 1.498%, while the two-year has risen to 0.238%, putting the gap at 1.26 percentage points. That so-called flattening of the yield curve is bad news for a rate-sensitive sector like banks. The SPDR S&amp;P Bank ETF fell 4.5% on Thurdsay and 1% in premarket trading on Friday. JPMorgan dropped 2.9% on Thursday and is down about 1% on Friday. S&amp;P 500 futures on Friday were down 0.6%, while Dow futures were down 0.8%. Futures for the Nasdaq Composite fell 0.4%.</p><p><blockquote>然而，市场已经改变了主意。10年期国债收益率跌至1.498%，两年期国债收益率升至0.238%，差距为1.26个百分点。对于银行等利率敏感行业来说，所谓的收益率曲线变平是个坏消息。SPDR S&amp;P Bank ETF周四下跌4.5%，周五盘前交易下跌1%。摩根大通周四下跌2.9%，周五下跌约1%。周五标普500期货下跌0.6%，道指期货下跌0.8%。纳斯达克综合指数期货下跌0.4%。</blockquote></p><p> Why the about-face from the market? For yields to keep rising, the economy needs to show that it is recovering quickly. Otherwise, investors are going to bet on a repeat of the slow growth the U.S. experienced after the financial crisis of 2008. With jobless claims missing by a wide margin Thursday—and experiencing the first rise following six weeks of drops—the market decided to focus on the latter, not the former, says Evercore ISI strategist Dennis DeBusschere. “The risk to the economic outlook is the sharp turn to hawkish side, relative to what everyone previously thought, at the same time the labor market isn’t as strong as the Fed assumed,” he writes.</p><p><blockquote>市场为何大转变？为了让收益率继续上升，经济需要表明它正在迅速复苏。否则，投资者将押注美国在2008年金融危机后经历的缓慢增长。Evercore ISI策略师丹尼斯·德布斯切尔(Dennis DeBusschere)表示，由于周四初请失业金人数大幅下降，并在六周下降后首次上升，市场决定关注后者，而不是前者。他写道：“相对于所有人之前的想法，经济前景面临的风险是急剧转向鹰派，同时劳动力市场并不像美联储假设的那么强劲。”</blockquote></p><p> Until that changes, it will be hard for bank stocks to bounce back.</p><p><blockquote>在这种情况改变之前，银行股将很难反弹。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bank Stocks Were Fed Day Winners. Why They’re Getting Crushed.<blockquote>银行股是美联储日的赢家。为什么他们会被压垮。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBank Stocks Were Fed Day Winners. Why They’re Getting Crushed.<blockquote>银行股是美联储日的赢家。为什么他们会被压垮。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-06-18 23:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Bank stocks rosewhen the Fed released its June monetary policy statement, one thatpointed to earlier than expected rate hikes. On Thursday, they were among the market’s biggest losers.</p><p><blockquote>当美联储发布6月份货币政策声明时，银行股上涨，该声明指出加息时间早于预期。周四，他们是市场最大的输家之一。</blockquote></p><p> There’s a good reason for that. Banks generally make money by borrowing money short and lending it out long—andmaking a profit off the spread. When longer-term rates rise faster than shorter-term ones, bank margins generally get better, while the profits deteriorate when the opposite happens.</p><p><blockquote>这是有充分理由的。银行通常通过短期借钱和长期借钱来赚钱，并从利差中获利。当长期利率上升速度快于短期利率时，银行利润率通常会提高，而当情况相反时，利润会恶化。</blockquote></p><p> After Wednesday’s meeting, the 10-year yield got a big bounce—it rose 0.071% to 1.569%—while thetwo-year yield rose0.038 percentage point to 0.203%, putting the spread between the two at 1.366 percentage points. That widening made the financial sector generally, and bank stocks specifically, one of the few sectors to react positively to the Fed’s announcement on Wednesday. TheSPDR S&amp;P Bank ETF(KBE) rose 0.9%, whileJPMorgan Chase(JPM) rose 0.7%, even as theS&amp;P 500fell 0.5%, theDow Jones Industrial Averagedropped 0.8%, and theNasdaq Compositedeclined 0.2%</p><p><blockquote>周三会议结束后，10年期国债收益率大幅反弹，上涨0.071%至1.569%，而两年期国债收益率上涨0.038个百分点至0.203%，两者利差达到1.366个百分点。这种扩大使得金融业，尤其是银行股成为少数几个对美联储周三的声明做出积极反应的行业之一。SPDR S&amp;P Bank ETF(KBE)上涨0.9%，摩根大通(JPM)上涨0.7%，尽管标准普尔500指数下跌0.5%，道琼斯工业平均指数下跌0.8%，纳斯达克综合指数下跌0.2%</blockquote></p><p> The market, however, has had a change of heart. The 10-year yield has fallen to 1.498%, while the two-year has risen to 0.238%, putting the gap at 1.26 percentage points. That so-called flattening of the yield curve is bad news for a rate-sensitive sector like banks. The SPDR S&amp;P Bank ETF fell 4.5% on Thurdsay and 1% in premarket trading on Friday. JPMorgan dropped 2.9% on Thursday and is down about 1% on Friday. S&amp;P 500 futures on Friday were down 0.6%, while Dow futures were down 0.8%. Futures for the Nasdaq Composite fell 0.4%.</p><p><blockquote>然而，市场已经改变了主意。10年期国债收益率跌至1.498%，两年期国债收益率升至0.238%，差距为1.26个百分点。对于银行等利率敏感行业来说，所谓的收益率曲线变平是个坏消息。SPDR S&amp;P Bank ETF周四下跌4.5%，周五盘前交易下跌1%。摩根大通周四下跌2.9%，周五下跌约1%。周五标普500期货下跌0.6%，道指期货下跌0.8%。纳斯达克综合指数期货下跌0.4%。</blockquote></p><p> Why the about-face from the market? For yields to keep rising, the economy needs to show that it is recovering quickly. Otherwise, investors are going to bet on a repeat of the slow growth the U.S. experienced after the financial crisis of 2008. With jobless claims missing by a wide margin Thursday—and experiencing the first rise following six weeks of drops—the market decided to focus on the latter, not the former, says Evercore ISI strategist Dennis DeBusschere. “The risk to the economic outlook is the sharp turn to hawkish side, relative to what everyone previously thought, at the same time the labor market isn’t as strong as the Fed assumed,” he writes.</p><p><blockquote>市场为何大转变？为了让收益率继续上升，经济需要表明它正在迅速复苏。否则，投资者将押注美国在2008年金融危机后经历的缓慢增长。Evercore ISI策略师丹尼斯·德布斯切尔(Dennis DeBusschere)表示，由于周四初请失业金人数大幅下降，并在六周下降后首次上升，市场决定关注后者，而不是前者。他写道：“相对于所有人之前的想法，经济前景面临的风险是急剧转向鹰派，同时劳动力市场并不像美联储假设的那么强劲。”</blockquote></p><p> Until that changes, it will be hard for bank stocks to bounce back.</p><p><blockquote>在这种情况改变之前，银行股将很难反弹。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/bank-stocks-were-fed-day-winners-why-theyre-getting-crushed-today-51623957525?mod=RTA\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行","GS":"高盛","MS":"摩根士丹利","BAC":"美国银行","JPM":"摩根大通","C":"花旗"},"source_url":"https://www.barrons.com/articles/bank-stocks-were-fed-day-winners-why-theyre-getting-crushed-today-51623957525?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119296361","content_text":"Bank stocks rosewhen the Fed released its June monetary policy statement, one thatpointed to earlier than expected rate hikes. On Thursday, they were among the market’s biggest losers.\nThere’s a good reason for that. Banks generally make money by borrowing money short and lending it out long—andmaking a profit off the spread. When longer-term rates rise faster than shorter-term ones, bank margins generally get better, while the profits deteriorate when the opposite happens.\nAfter Wednesday’s meeting, the 10-year yield got a big bounce—it rose 0.071% to 1.569%—while thetwo-year yield rose0.038 percentage point to 0.203%, putting the spread between the two at 1.366 percentage points. That widening made the financial sector generally, and bank stocks specifically, one of the few sectors to react positively to the Fed’s announcement on Wednesday. TheSPDR S&P Bank ETF(KBE) rose 0.9%, whileJPMorgan Chase(JPM) rose 0.7%, even as theS&P 500fell 0.5%, theDow Jones Industrial Averagedropped 0.8%, and theNasdaq Compositedeclined 0.2%\nThe market, however, has had a change of heart. The 10-year yield has fallen to 1.498%, while the two-year has risen to 0.238%, putting the gap at 1.26 percentage points. That so-called flattening of the yield curve is bad news for a rate-sensitive sector like banks. The SPDR S&P Bank ETF fell 4.5% on Thurdsay and 1% in premarket trading on Friday. JPMorgan dropped 2.9% on Thursday and is down about 1% on Friday. S&P 500 futures on Friday were down 0.6%, while Dow futures were down 0.8%. Futures for the Nasdaq Composite fell 0.4%.\nWhy the about-face from the market? For yields to keep rising, the economy needs to show that it is recovering quickly. Otherwise, investors are going to bet on a repeat of the slow growth the U.S. experienced after the financial crisis of 2008. With jobless claims missing by a wide margin Thursday—and experiencing the first rise following six weeks of drops—the market decided to focus on the latter, not the former, says Evercore ISI strategist Dennis DeBusschere. “The risk to the economic outlook is the sharp turn to hawkish side, relative to what everyone previously thought, at the same time the labor market isn’t as strong as the Fed assumed,” he writes.\nUntil that changes, it will be hard for bank stocks to bounce back.","news_type":1,"symbols_score_info":{"JPM":0.9,"MS":0.9,"C":0.9,"WFC":0.9,"BAC":0.9,"GS":0.9}},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173223048,"gmtCreate":1626663498784,"gmtModify":1631884682369,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>go go go. Go up.","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>go go go. Go up.","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$go go go. Go up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/173223048","isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156163559,"gmtCreate":1625202972371,"gmtModify":1631884682422,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>too high to go in now?","listText":"<a href=\"https://laohu8.com/S/QC7.SI\">$Q &amp; M DENTAL GROUP (S) LIMITED(QC7.SI)$</a>too high to go in now?","text":"$Q & M DENTAL GROUP (S) LIMITED(QC7.SI)$too high to go in now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/156163559","isVote":1,"tweetType":1,"viewCount":626,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158831325,"gmtCreate":1625142685067,"gmtModify":1631888415172,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","text":"$KEPPEL DC REIT(AJBU.SI)$what happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/158831325","isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150023113,"gmtCreate":1624876953232,"gmtModify":1631890772590,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Woohoo","listText":"Woohoo","text":"Woohoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/150023113","repostId":"1164938136","repostType":4,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167644517,"gmtCreate":1624267542139,"gmtModify":1634008668691,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Interesting.&nbsp;","listText":"Interesting.&nbsp;","text":"Interesting.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167644517","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=zh_CN&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme盘前交易涨超6%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p><p><blockquote>（6月21日）Orphazyme盘前交易涨超6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p><p><blockquote>本公司之股份<b>Orphazyme</b>一家处于临床阶段的生物制药公司在食品和药物管理局(FDA)拒绝批准该公司主要候选药物的申请后受到了打击。投资者现在不确定该生物技术公司何时可以获得批准的产品出售，截至中午12点12分，该股股价下跌44.4%。上周五美国东部时间。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p><p><blockquote>FDA去年9月开始审查Orphazyme的主要候选药物arimoclomol的申请，作为一种罕见但危及生命的疾病（称为C型奈曼-皮克病(NPC)）的潜在治疗方法。本月早些时候，由于预期绿灯从未到来，Orphazymes的股价飙升超过200%。</blockquote></p><p> Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p><p><blockquote>该机构没有对arimoclomol做出批准决定，而是以完整回复信(CRL)的形式要求提供更多信息。这让许多刚接触复杂的药物开发领域并预计会出现大规模轧空的投资者感到震惊。</blockquote></p><p> Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p><p><blockquote>许多机构投资者对Orphazyme做空，因为其主要候选药物未能达到支持该申请的关键研究的主要终点。Arimoclomol也未能改善患者在FDA特别要求的次要终点上的评分。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p><p><blockquote>据Orphazyme称，该公司需要进一步证实arimoclomol几乎达到的主要终点的有效性。为了让FDA满意，该公司很可能必须进行一项新的关键研究。</blockquote></p><p> Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p><p><blockquote>一些股东仍然希望欧洲药品管理局不会像FDA那样严格。虽然FDA的欧洲同事过去对罕见疾病的治疗更加宽容，但在产生一些令人信服的临床试验结果之前，arimoclomol可能不会向前推进。</blockquote></p><p> Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p><p><blockquote>尽管缺乏明确的前进道路，但这家总部位于丹麦的公司仍然拥有相当大的市值，按最近的价格计算超过5亿美元。非理性的预期可能会使其居高不下，但对于Orphazyme的任何临床阶段生物技术来说，这都太高了。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme盘前交易涨超6%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading<blockquote>Orphazyme盘前交易涨超6%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-21 17:17</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p><p><blockquote>（6月21日）Orphazyme盘前交易涨超6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p><p><blockquote>本公司之股份<b>Orphazyme</b>一家处于临床阶段的生物制药公司在食品和药物管理局(FDA)拒绝批准该公司主要候选药物的申请后受到了打击。投资者现在不确定该生物技术公司何时可以获得批准的产品出售，截至中午12点12分，该股股价下跌44.4%。上周五美国东部时间。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p><p><blockquote>FDA去年9月开始审查Orphazyme的主要候选药物arimoclomol的申请，作为一种罕见但危及生命的疾病（称为C型奈曼-皮克病(NPC)）的潜在治疗方法。本月早些时候，由于预期绿灯从未到来，Orphazymes的股价飙升超过200%。</blockquote></p><p> Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p><p><blockquote>该机构没有对arimoclomol做出批准决定，而是以完整回复信(CRL)的形式要求提供更多信息。这让许多刚接触复杂的药物开发领域并预计会出现大规模轧空的投资者感到震惊。</blockquote></p><p> Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p><p><blockquote>许多机构投资者对Orphazyme做空，因为其主要候选药物未能达到支持该申请的关键研究的主要终点。Arimoclomol也未能改善患者在FDA特别要求的次要终点上的评分。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p><p><blockquote>据Orphazyme称，该公司需要进一步证实arimoclomol几乎达到的主要终点的有效性。为了让FDA满意，该公司很可能必须进行一项新的关键研究。</blockquote></p><p> Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p><p><blockquote>一些股东仍然希望欧洲药品管理局不会像FDA那样严格。虽然FDA的欧洲同事过去对罕见疾病的治疗更加宽容，但在产生一些令人信服的临床试验结果之前，arimoclomol可能不会向前推进。</blockquote></p><p> Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p><p><blockquote>尽管缺乏明确的前进道路，但这家总部位于丹麦的公司仍然拥有相当大的市值，按最近的价格计算超过5亿美元。非理性的预期可能会使其居高不下，但对于Orphazyme的任何临床阶段生物技术来说，这都太高了。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164934540,"gmtCreate":1624164924480,"gmtModify":1634009921546,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586573341987690","idStr":"3586573341987690"},"themes":[],"htmlText":"Article to instill fear?","listText":"Article to instill fear?","text":"Article to instill fear?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164934540","repostId":"1183124175","repostType":4,"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}